Pacific Biosciences of California (NASDAQ:PACB) Now Covered by Jefferies Financial Group
Analysts at Jefferies Financial Group assumed coverage on shares of Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) in a research note issued on Monday, MarketBeat reports. The brokerage set a “buy” rating and a $4.00 price target on the biotechnology company’s stock. Jefferies Financial Group’s price objective suggests a potential upside of 122.22% […]
More Stories
dogwifhat (WIF) Price Up 20.3% Over Last 7 Days
dogwifhat (WIF) traded up 12.9% against the US dollar during the one day period ending at 19:00 PM E.T. on...
dogwifhat (WIF) Price Up 20.3% Over Last 7 Days
dogwifhat (WIF) traded up 12.9% against the US dollar during the one day period ending at 19:00 PM E.T. on...
Charles Schwab Trust Co Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)
Charles Schwab Trust Co trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 42.6% during the third...
Charles Schwab Trust Co Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)
Charles Schwab Trust Co trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 42.6% during the third...
San Luis Wealth Advisors LLC Boosts Stock Position in Adobe Inc. (NASDAQ:ADBE)
San Luis Wealth Advisors LLC boosted its holdings in Adobe Inc. (NASDAQ:ADBE – Free Report) by 5.1% during the third...
San Luis Wealth Advisors LLC Boosts Stock Position in Adobe Inc. (NASDAQ:ADBE)
San Luis Wealth Advisors LLC boosted its holdings in Adobe Inc. (NASDAQ:ADBE – Free Report) by 5.1% during the third...